search
Back to results

PRE-STARt Intervention - Trial of an Interactive Family Based Lifestyle Programme

Primary Purpose

Type 2 Diabetes, Chronic Disease, Obesity

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Interactive Lifestyle programme workshop
Sponsored by
University Hospitals, Leicester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Type 2 Diabetes

Eligibility Criteria

12 Years - 14 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Parents/guardians will answer questions in the eligibility questionnaire about their child and family health history. Participants will be invited to participate if they are 12-14 years old inclusive (12 years 0 days to 14 years 354 days old) and are identified as having the following risk factors for development of Type 2 Diabetes (which will be identified from the eligibility questionnaire):

BMI > 95th percentile for age and gender OR

BMI > 85th percentile PLUS one other from the following list:

  • Family history of Diabetes (first degree relative).
  • Non-white ethnicity.
  • Watching TV/play computer games for more than 2 hours a day (self-report).
  • Sugar intake more than 1.5 cans (or 532 ml) of fizzy pop/fruit juice per day (self-report).

Exclusion Criteria:

Young people will not be eligible for participation in the study if they are outside the age range of interest (<11 years and 364 days or >14 years and 1 day), have an existing diagnosis of Type 1 or Type 2 Diabetes, < 85th percentile. Young people will also be excluded if they themselves do not provide written assent or their parent/guardian does not provide written consent.

Sites / Locations

  • University Hospitals of Leicester

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Other

Arm Label

Control

Intervention

Arm Description

The control participants will not receive the educational intervention but will be provided with a detailed advice leaflet for themselves and their parents/guardians.

The educational intervention participants will receive the eight 90 minute sessions of an interactive family based lifestyle programme.

Outcomes

Primary Outcome Measures

The primary endpoint is to detect a change in objectively measured MVPA of 10 minutes per day within the intervention group at 6 months.
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.

Secondary Outcome Measures

An increase in total volume of physical activity
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
An increase in the proportion meeting MVPA guidelines
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
Reduction in time spent sedentary
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
Change in physical activity levels
Self reported - questionnaire
Reduction in Body mass index percentile (BMI)
Body mass will be measured to the nearest 0.1kg and height will be measured to the nearest 0.1 cm using a clinically approved bioelectrical impedance scale and a portable stadiometer, respectively. BMI will be calculated as weight/height2 and will be converted to a BMI percentile based on WHO growth charts
Change in healthy food provision and parenting practices for healthy food
As parents are active participants in the intervention The Investigators will also query their knowledge and attitudes towards healthy eating and physical activity.
Improvement in diet composition
The Investigators will query the nutrition habits of participants to investigate any changes in the behaviours targeted in the workshops. A food frequency questionnaire (FFQ) taken from the ISCOLE study that was adapted from the HBSC Study will be used to query the consumption of 23 food categories in a "usual" week. The Investigators will also query breakfast consumption for weekdays and weekends. The Investigators have also created ad hoc questions on other intervention targets of snacking behaviours, fruit and vegetable intake and fizzy drink consumption. This ad hoc method has been used in other international multi-site studies.
Improvement in knowledge of physical activity and nutrition
The physical activity questionnaire for adolescents (PAQ-A) [62] will be used to assess the Types and context of physical activity in order to investigate changes in the Types of sports/exercise/activities the participating child may participate in (information which is not available from the accelerometer or the majority of other validated self-report questionnaires). This questionnaire requests responses for the last 7 days by asking participants to check a list of activities for frequency of participation. This questionnaire has received support from an expert panel and has also high validity against objective measures and moderate reliability.
Improvement in HbA1c
Biochemical measures (Child only) - HbA1c
Improvement in Triglycerides
Biochemical measures (Child only) - Triglycerides
Improvement in Glucose
Biochemical measures (Child only) - Glucose
Improvement in HDL-C
Biochemical measures (Child only) HDL-C
Improvement in Total Cholesterol
Biochemical measures (Child only) -Total cholesterol will be measured using a point-of-care testing (POCT) and LDL-C will be calculated.
Improvement in cardio-metabolic variables
Biochemical measures (Child only) - Capillary blood samples will be taken from each child using the finger prick method. The CardioChek® system will be used as the POCT method. The CardioChek® system is a portable hand held device that requires between 15 to 40 µL capillary sample from a finger-stick for each test. The CardioChek® system is certified by the Cholesterol Reference Method Laboratory Network (CRMLN) and National Cholesterol Education Program (NCEP), is FDA-cleared, CE-marked, internationally registered, and is CLIA-waived by the Centers for Medicare & Medicaid Services, USA.
Blood Pressure (Child)
Arterial blood pressure will be measured using an automated sphygmomanometer with an appropriate sized cuff while the patient is seated, and having rested quietly for 5 minutes. Three measurements will be obtained for blood pressure and an average of the last two will be used in any analysis.
Blood Pressure (Parent(s)/guardian(s))
Arterial blood pressure will be measured using an automated sphygmomanometer with an appropriate sized cuff while the patient is seated, and having rested quietly for 5 minutes. Three measurements will be obtained for blood pressure and an average of the last two will be used in any analysis.

Full Information

First Posted
May 5, 2016
Last Updated
January 14, 2019
Sponsor
University Hospitals, Leicester
Collaborators
University of Leicester, Associacao Protectora dos Diabeticos de Portugal, The Algarve Regional Health Administration, University of Leipzig, Technische Universität Dresden, Alexander Technological Educational Institute, Thessaloniki, Greece, Diabetes Centre of Paediatrics P&A, Primary Care Centre Egia, San Sebastian, Spain, Basque Government Department of Public Health, Health Department of the Alto/Bajo Deba
search

1. Study Identification

Unique Protocol Identification Number
NCT02845791
Brief Title
PRE-STARt Intervention - Trial of an Interactive Family Based Lifestyle Programme
Official Title
Prevention Strategies for Adolescents at Risk of Diabetes - A Randomised Controlled Trial of an Interactive Family-based Lifestyle Programme
Study Type
Interventional

2. Study Status

Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
July 2016 (undefined)
Primary Completion Date
March 2017 (Actual)
Study Completion Date
October 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospitals, Leicester
Collaborators
University of Leicester, Associacao Protectora dos Diabeticos de Portugal, The Algarve Regional Health Administration, University of Leipzig, Technische Universität Dresden, Alexander Technological Educational Institute, Thessaloniki, Greece, Diabetes Centre of Paediatrics P&A, Primary Care Centre Egia, San Sebastian, Spain, Basque Government Department of Public Health, Health Department of the Alto/Bajo Deba

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To investigate whether the interactive family based lifestyle programme leads to behaviour change at 6 months with the primary outcome being increased levels of moderate to vigorous physical activity (MVPA).
Detailed Description
To investigate whether the lifestyle programme results in changes to the following outcomes 3 and 6 months after baseline assessment (Child) An increase in objectively measured total amount of physical activity An increase in the proportion meeting MVPA guidelines (measured objectively) Reduction in time spent sedentary (measured objectively and self-reported) Change in self-reported physical activity Reduction in measures of adiposity (body mass index percentile, per cent body fat) Improvement in psychological factors that may mediate physical activity participation (self-efficacy, motivation, attitudes, social support and enjoyment of physical activity; and physical self-perceptions) Change in healthy food provision and parenting practices for healthy food Improvement in diet composition. Improvement in knowledge of physical activity and nutrition. Improvement in cardio-metabolic variables (blood pressure, glucose, HbA1c, cholesterol) The Investigators will also include qualitative data collected from: Evaluation forms following each intervention workshop session which will be completed by the Parent/guardian, child and facilitator Feedback from focus groups to be held following completion of the total intervention i.e. 8 sessions To investigate whether the lifestyle programme results in changes to the following outcomes 3 and 6 months after baseline assessment (Parent(s)/guardian(s)) An increase in objectively measured total volume of physical activity An increase in the proportion meeting MVPA guidelines (measured objectively) Reduction in time spent sedentary (measured objectively and self-reported) Change in self-reported physical activity Reduction in measures of adiposity (body mass index percentile, per cent body fat) Change in healthy food provision and parenting practices for healthy food Improvement in diet composition. Improvement in knowledge of physical activity and nutrition.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes, Chronic Disease, Obesity

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
318 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
The control participants will not receive the educational intervention but will be provided with a detailed advice leaflet for themselves and their parents/guardians.
Arm Title
Intervention
Arm Type
Other
Arm Description
The educational intervention participants will receive the eight 90 minute sessions of an interactive family based lifestyle programme.
Intervention Type
Behavioral
Intervention Name(s)
Interactive Lifestyle programme workshop
Intervention Description
Participants will attend eight 90 minute sessions of an interactive lifestyle programme along with their parent(s)/guardian(s).
Primary Outcome Measure Information:
Title
The primary endpoint is to detect a change in objectively measured MVPA of 10 minutes per day within the intervention group at 6 months.
Description
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
Time Frame
6 months post baseline
Secondary Outcome Measure Information:
Title
An increase in total volume of physical activity
Description
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
Time Frame
3 and 6 months
Title
An increase in the proportion meeting MVPA guidelines
Description
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
Time Frame
3 and 6 months
Title
Reduction in time spent sedentary
Description
Participating children and adults will be asked to wear the wrist worn GENEActiv accelerometer (ActivInsights, Kimbolton, Cambridgeshire, UK) continuously for up to 8 days.
Time Frame
3 and 6 months
Title
Change in physical activity levels
Description
Self reported - questionnaire
Time Frame
3 and 6 months
Title
Reduction in Body mass index percentile (BMI)
Description
Body mass will be measured to the nearest 0.1kg and height will be measured to the nearest 0.1 cm using a clinically approved bioelectrical impedance scale and a portable stadiometer, respectively. BMI will be calculated as weight/height2 and will be converted to a BMI percentile based on WHO growth charts
Time Frame
3 and 6 months
Title
Change in healthy food provision and parenting practices for healthy food
Description
As parents are active participants in the intervention The Investigators will also query their knowledge and attitudes towards healthy eating and physical activity.
Time Frame
3 and 6 months
Title
Improvement in diet composition
Description
The Investigators will query the nutrition habits of participants to investigate any changes in the behaviours targeted in the workshops. A food frequency questionnaire (FFQ) taken from the ISCOLE study that was adapted from the HBSC Study will be used to query the consumption of 23 food categories in a "usual" week. The Investigators will also query breakfast consumption for weekdays and weekends. The Investigators have also created ad hoc questions on other intervention targets of snacking behaviours, fruit and vegetable intake and fizzy drink consumption. This ad hoc method has been used in other international multi-site studies.
Time Frame
3 and 6 months
Title
Improvement in knowledge of physical activity and nutrition
Description
The physical activity questionnaire for adolescents (PAQ-A) [62] will be used to assess the Types and context of physical activity in order to investigate changes in the Types of sports/exercise/activities the participating child may participate in (information which is not available from the accelerometer or the majority of other validated self-report questionnaires). This questionnaire requests responses for the last 7 days by asking participants to check a list of activities for frequency of participation. This questionnaire has received support from an expert panel and has also high validity against objective measures and moderate reliability.
Time Frame
3 and 6 months
Title
Improvement in HbA1c
Description
Biochemical measures (Child only) - HbA1c
Time Frame
3 and 6 months
Title
Improvement in Triglycerides
Description
Biochemical measures (Child only) - Triglycerides
Time Frame
3 and 6 months
Title
Improvement in Glucose
Description
Biochemical measures (Child only) - Glucose
Time Frame
3 and 6 months
Title
Improvement in HDL-C
Description
Biochemical measures (Child only) HDL-C
Time Frame
3 and 6 months
Title
Improvement in Total Cholesterol
Description
Biochemical measures (Child only) -Total cholesterol will be measured using a point-of-care testing (POCT) and LDL-C will be calculated.
Time Frame
3 and 6 months
Title
Improvement in cardio-metabolic variables
Description
Biochemical measures (Child only) - Capillary blood samples will be taken from each child using the finger prick method. The CardioChek® system will be used as the POCT method. The CardioChek® system is a portable hand held device that requires between 15 to 40 µL capillary sample from a finger-stick for each test. The CardioChek® system is certified by the Cholesterol Reference Method Laboratory Network (CRMLN) and National Cholesterol Education Program (NCEP), is FDA-cleared, CE-marked, internationally registered, and is CLIA-waived by the Centers for Medicare & Medicaid Services, USA.
Time Frame
3 and 6 months
Title
Blood Pressure (Child)
Description
Arterial blood pressure will be measured using an automated sphygmomanometer with an appropriate sized cuff while the patient is seated, and having rested quietly for 5 minutes. Three measurements will be obtained for blood pressure and an average of the last two will be used in any analysis.
Time Frame
3 and 6 months
Title
Blood Pressure (Parent(s)/guardian(s))
Description
Arterial blood pressure will be measured using an automated sphygmomanometer with an appropriate sized cuff while the patient is seated, and having rested quietly for 5 minutes. Three measurements will be obtained for blood pressure and an average of the last two will be used in any analysis.
Time Frame
3 and 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Parents/guardians will answer questions in the eligibility questionnaire about their child and family health history. Participants will be invited to participate if they are 12-14 years old inclusive (12 years 0 days to 14 years 354 days old) and are identified as having the following risk factors for development of Type 2 Diabetes (which will be identified from the eligibility questionnaire): BMI > 95th percentile for age and gender OR BMI > 85th percentile PLUS one other from the following list: Family history of Diabetes (first degree relative). Non-white ethnicity. Watching TV/play computer games for more than 2 hours a day (self-report). Sugar intake more than 1.5 cans (or 532 ml) of fizzy pop/fruit juice per day (self-report). Exclusion Criteria: Young people will not be eligible for participation in the study if they are outside the age range of interest (<11 years and 364 days or >14 years and 1 day), have an existing diagnosis of Type 1 or Type 2 Diabetes, < 85th percentile. Young people will also be excluded if they themselves do not provide written assent or their parent/guardian does not provide written consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Melanie J Davies, MD
Organizational Affiliation
University Hospitals, Leicester
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospitals of Leicester
City
Leicester
ZIP/Postal Code
LE4 5PW
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Non identifiable participant data will be only be shared with the study collaborators.

Learn more about this trial

PRE-STARt Intervention - Trial of an Interactive Family Based Lifestyle Programme

We'll reach out to this number within 24 hrs